Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 08 Oct 2026 for Relay Therapeutics, Inc., €776k. Read the official filing
Filing timeline
BuySaleSanjiv Patel
Insider track record
Disclosed buys
0
Disclosed sells
10
Signal history
Sanjiv Patel: trading record in brief
Sanjiv Patel (chief executive) discloses dealings in Relay Therapeutics, Inc. to SEC (Form 4). We count 25 filings; the first trade dates from 31 December 2021 and the latest from 7 October 2026.
No open-market purchase appears, only 10 sales worth €5.4M. Other entries cover 8 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
On 8 October 2026 came the latest disclosure, an open-market sale for €776k in Relay Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sanjiv Patel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
48,199 shares@ US$18.10Common StockSEC:0001193125-26-418096:0
48,199 shares@ US$18.940.023% mcap14.8% of flowCommon StockSEC:0001193125-26-386455:0
48,199 shares@ US$20.330.024% mcap16.0% of flowCommon StockSEC:0001193125-26-355502:0
3,056 shares@ US$6.950.0005% mcap0.4% of flowCommon StockSEC:0001193125-26-298681:0
48,199 shares@ US$19.580.024% mcap15.6% of flowCommon StockSEC:0001193125-26-298681:1
994 shares@ US$2.990.0% of flowCommon StockSEC:0001193125-26-006328:0
62,073 shares@ US$7.007.1% of flowCommon StockSEC:0001193125-25-264700:0
42,740 shares@ US$3.572.5% of flowCommon StockSEC:0000950170-25-095093:0
5,000 shares@ US$2.940.2% of flowCommon StockSEC:0000950170-25-092305:0
42,769 shares@ US$2.972.1% of flowCommon StockSEC:0000950170-25-057996:0
140,182 shares@ US$3.859.9% of flowCommon StockSEC:0000950170-25-020272:0
125,000 shares@ US$4.5210.2% of flowCommon StockSEC:0000950170-25-008451:0
100,000 shares@ US$5.009.0% of flowCommon StockSEC:0000950170-24-137960:0
50,000 shares@ US$5.044.4% of flowCommon StockSEC:0000950170-24-087435:0
2,108 shares@ US$5.540.2% of flowCommon StockSEC:0000950170-24-079693:0
762,360 shares0Common StockSEC:0001209191-24-001843:0
1,662 shares@ US$10.680.3% of flowCommon StockSEC:0001209191-23-050874:0
14,000 shares@ US$5.041.2% of flowCommon StockSEC:0001209191-23-008072:0
28,000 shares@ US$5.042.5% of flowCommon StockSEC:0001209191-23-004127:0
14,000 shares@ US$4.121.1% of flowCommon StockSEC:0001209191-22-056427:0
14,000 shares@ US$4.121.1% of flowCommon StockSEC:0001209191-22-053597:0
14,000 shares@ US$4.121.1% of flowCommon StockSEC:0001209191-22-050182:0
814 shares@ US$14.240.2% of flowCommon StockSEC:0001209191-22-041639:0
28,000 shares@ US$4.1287.5% of flowCommon StockSEC:0001209191-22-024487:0
658 shares@ US$26.1012.5% of flowCommon StockSEC:0001209191-22-002465:0
25 of 25 declarations
